Major, Inc.
MAJOR INC conducts life‑sciences and biotechnology research focused on developing noninvasive, preventative therapeutics. The organization works with academic partners to advance preclinical programs aimed at reducing viral load and infection, and publishes and shares research outputs and collaboration opportunities.
Industries
Nr. of Employees
small (1-50)
Services
Partnering with academic groups and external collaborators to advance research programs and share findings.
Preclinical testing and evaluation of therapeutic candidates, including efficacy assessments intended for prophylactic use.
Partnering with academic groups and external collaborators to advance research programs and share findings.
Preclinical testing and evaluation of therapeutic candidates, including efficacy assessments intended for prophylactic use.
Expertise Areas
- Antiviral therapeutics research
- Preclinical development and in vivo efficacy testing
- Peptidomimetic drug discovery
- Translational research
Key Technologies
- Peptidomimetic (peptoid) chemistry
- Preclinical in vivo models
- Antiviral prophylactic therapeutics
- Assay-based candidate screening
News & Updates
Research referenced on the site via an MDPI link (listed under 'Our Research').
Site reports early preclinical results indicating a significant prophylactic effect for their therapeutic approach to reduce COVID-19 viral load and infection.
Research referenced on the site via an MDPI link (listed under 'Our Research').
Site reports early preclinical results indicating a significant prophylactic effect for their therapeutic approach to reduce COVID-19 viral load and infection.